Cladribine Tablets Receives Positive CHMP Opinion for Treatment of Relapsing Forms of Multiple Sclerosis
Download PDF Read more
Category: PR/Corporate
Presentation confirms Venclexta/Venclyxto monotherapy benefit in certain patients with high-risk chronic lymphocytic leukaemia and its potential in other hard-to-treat blood cancers
Basel, 23 June 2017 Presentation confirms Venclexta/Venclyxto monotherapy benefit in certain patients with high-risk chronic lymphocytic leukaemia and its potential in other hard-to-treat blood cancers First in class BCL2-specific oral inhibitor represents a potential new way of treating different blood cancers Efficacy and tolerability confirmed in high-risk patients with relapsed or refractory chronic lymphocytic leukaemia,... Read more
Roche presents new data from GALLIUM study reinforcing clinical benefit of Gazyva/Gazyvaro in people with previously untreated follicular lymphoma
Basel, 23 June 2017 Roche presents new data from GALLIUM study reinforcing clinical benefit of Gazyva/Gazyvaro in people with previously untreated follicular lymphoma Longer follow-up showed sustained benefit in progression-free survival of Gazyva/Gazyvaro-based treatment over MabThera/Rituxan-based treatment regardless of chemotherapy regimens People with follicular lymphoma who received Gazyva/Gazyvaro-based treatment reported improvement in health-related quality of... Read more
New data at EAN show Roche’s OCREVUS™ (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary progressive multiple sclerosis
Basel, 23 June 2017 New data at EAN show Roche’s OCREVUS™ (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary progressive multiple sclerosis OCREVUS increased the number of patients with relapsing MS (RMS) and primary progressive MS (PPMS) who maintained No Evidence of Progression or Active Disease (NEPAD) versus Rebif (interferon beta-1a)... Read more
Waters Corporation Elects Flemming Ornskov to Board of Directors
June 22, 2017 04:30 AM Pacific Daylight Time MILFORD, Mass.–(BUSINESS WIRE)–Waters Corporation (NYSE: WAT) today announced Dr. Flemming Ornskov, Chief Executive Officer of Shire plc, has been elected as a Director of Waters® Corporation effective today. “It is an honor to welcome Flemming Ornskov to our Board of Directors,” said Christopher J. O’Connell, Waters Corporation President... Read more
New York High School Students Win 2017 U.S. Stockholm Junior Water Prize
RYE BROOK, N.Y.–(BUSINESS WIRE)–Jun. 20, 2017– Xylem Inc. (NYSE:XYL), a leading global water technology and solutions company, congratulates Rachel Chang and Ryan Thorpe of Manhasset, N.Y., the 2017 winners of the United States Stockholm Junior Water Prize (SJWP), the most prestigious youth award for a water-related research project. Xylem has been a long-time leading sponsor... Read more
BASi Names Dr. Gregory C. Davis to Board of Directors
PRESS RELEASE UPDATED: JUN 20, 2017 WEST LAFAYETTE, IN, June 20, 2017 (Newswire.com) – Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that the board of directors unanimously elected Dr. Gregory C. Davis as a director effective June 14, 2017. This action brings the number of directors to four. Larry Boulet, BASi’s Chairman... Read more
Danaher Announces Pricing Of Euro-Denominated Senior Notes Offering
WASHINGTON, June 20, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that its wholly-owned subsidiary, DH Europe Finance S.A. (“Danaher International”), has priced an offering of: €250 million principal amount of floating rate senior notes due 2022 at an offering price of 100.147% of the principal amount; and €600 million principal amount of... Read more
BD Receives FDA 510(k) Clearance for New Line of Customizable, 3.0mm Micro-Laparoscopic Instruments
FRANKLIN LAKES, N.J., June 20, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its new line of Snowden-Pencer™ 3.0mm laparoscopic ergonomic take-apart instruments received U.S. Food and Drug Administration (FDA) 510(k) clearance for use in laparoscopic surgery. The new line of Snowden-Pencer 3.0mm laparoscopic... Read more
VWR Proudly Sponsors the Start-Up Stadium at the BIO International Convention in San Diego, California
RADNOR, Pa., June 20, 2017 /PRNewswire/ — VWR (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, is proud to be a sponsor of the Start-Up Stadium at the BIO International Convention for the third year in a row. Over the course of the next three days, 40 start-ups will present a 5 to... Read more